Cystatin C compared to serum creatinine as a marker of acute kidney injury in critically ill neonates

ConclusionsCysC may be used as a screening biomarker of AKI in critically ill neonates; yet, it was not superior to serum creatinine.Graphical abstract
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research